240 related articles for article (PubMed ID: 32334898)
1. Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prevention in Patients Undergoing Revision Total Hip Arthroplasty: A Retrospective Cohort Study.
Tang A; Zak S; Iorio R; Slover J; Bosco J; Schwarzkopf R
J Arthroplasty; 2020 Aug; 35(8):2182-2187. PubMed ID: 32334898
[TBL] [Abstract][Full Text] [Related]
2. Low-Dose Aspirin is Safe and Effective for Venous Thromboembolism Prevention in Patients Undergoing Revision Total Knee Arthroplasty: A Retrospective Cohort Study.
Tang A; Zak SG; Waren D; Iorio R; Slover JD; Bosco JA; Schwarzkopf R
J Knee Surg; 2022 Apr; 35(5):553-559. PubMed ID: 32898907
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Use for Venous Thromboembolism Prevention Is Safe and Effective in Overweight and Obese Patients Undergoing Revision Total Hip and Knee Arthroplasty.
Tang A; Sicat CS; Singh V; Rozell JC; Schwarzkopf R; Long WJ
J Arthroplasty; 2021 Jul; 36(7S):S337-S344. PubMed ID: 33376036
[TBL] [Abstract][Full Text] [Related]
4. Thirty day low-dose versus regular-dose aspirin for venous thromboembolism prophylaxis in primary total joint arthroplasty.
Duke AJ; Bowen S; Baig S; Cohen D; Komatsu DE; Nicholson J
J Orthop Surg (Hong Kong); 2023; 31(2):10225536231173329. PubMed ID: 37137821
[TBL] [Abstract][Full Text] [Related]
5. Discontinued Use of Outpatient Portable Intermittent Pneumatic Compression Devices May Be Safe for Venous Thromboembolism Prophylaxis in Primary Total Knee Arthroplasty Using Low-Dose Aspirin.
Tang A; Zak S; Lygrisse K; Slover J; Meftah M; Lajam C; Schwarzkopf R; Macaulay W
J Knee Surg; 2022 Jul; 35(8):909-915. PubMed ID: 33241544
[TBL] [Abstract][Full Text] [Related]
6. No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.
Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
Clin Orthop Relat Res; 2019 Feb; 477(2):396-402. PubMed ID: 30624322
[TBL] [Abstract][Full Text] [Related]
7. Venous Thromboembolism Rates Did Not Decrease in Lower Extremity Revision Total Joint Arthroplasty From 2008 to 2016.
Warren JA; Sundaram K; Kamath AF; Molloy RM; Krebs VE; Mont MA; Piuzzi NS
J Arthroplasty; 2019 Nov; 34(11):2774-2779. PubMed ID: 31153709
[TBL] [Abstract][Full Text] [Related]
8. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prophylaxis Following Total Knee Arthroplasty.
Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
J Arthroplasty; 2018 Jul; 33(7S):S131-S135. PubMed ID: 29656974
[TBL] [Abstract][Full Text] [Related]
10. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
Hovik O; Amlie EJ; Jenssen KK
J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors associated with venous thromboembolism following primary total hip arthroplasty in low-risk patients when using aspirin for prophylaxis.
Howard TA; Judd CS; Snowden GT; Lambert RJ; Clement ND
Hip Int; 2022 Sep; 32(5):562-567. PubMed ID: 33594900
[TBL] [Abstract][Full Text] [Related]
12. Weight-Based Aspirin Dosing May Further Reduce the Incidence of Venous Thromboembolism Following Primary Total Joint Arthroplasty.
Halbur CR; Gulbrandsen TR; West CR; Brown TS; Noiseux NO
J Arthroplasty; 2021 Dec; 36(12):3986-3992.e1. PubMed ID: 34215460
[TBL] [Abstract][Full Text] [Related]
13. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Revision Hip and Knee Arthroplasty as Reported by American Board of Orthopaedic Surgery Part II Candidates.
Runner RP; Shau DN; Staley CA; Roberson JR
J Arthroplasty; 2021 Jul; 36(7):2364-2370. PubMed ID: 33674164
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose vs Regular-Dose Aspirin for Venous Thromboembolism Prophylaxis in Primary Total Joint Arthroplasty.
Uvodich ME; Siljander MP; Taunton MJ; Mabry TM; Perry KI; Abdel MP
J Arthroplasty; 2021 Jul; 36(7):2359-2363. PubMed ID: 33640184
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Is as Effective as and Safer Than Warfarin for Patients at Higher Risk of Venous Thromboembolism Undergoing Total Joint Arthroplasty.
Huang RC; Parvizi J; Hozack WJ; Chen AF; Austin MS
J Arthroplasty; 2016 Sep; 31(9 Suppl):83-6. PubMed ID: 27094242
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
Goel R; Fleischman AN; Tan T; Sterbis E; Huang R; Higuera C; Parvizi J; Rothman RH
Bone Joint J; 2018 Jan; 100-B(1 Supple A):68-75. PubMed ID: 29292343
[TBL] [Abstract][Full Text] [Related]
17. Aspirin Is Safe for Venous Thromboembolism Prophylaxis for Patients With a History of Gastrointestinal Issues.
Grosso MJ; Kozaily E; Parvizi J; Austin MS
J Arthroplasty; 2021 Jul; 36(7S):S332-S336. PubMed ID: 33610409
[TBL] [Abstract][Full Text] [Related]
18. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
Arsoy D; Giori NJ; Woolson ST
Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
[TBL] [Abstract][Full Text] [Related]
19. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
Asopa V; Cobain W; Martin D; Keene G; Bauze A
ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
[TBL] [Abstract][Full Text] [Related]
20. Multimodal thromboprophylaxis in low-risk patients undergoing lower limb arthroplasty: A retrospective observational cohort analysis of 1400 patients with ultrasound screening.
Harrison-Brown M; Scholes C; Douglas SL; Farah SB; Kerr D; Kohan L
J Orthop Surg (Hong Kong); 2020; 28(2):2309499020926790. PubMed ID: 32484038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
